Expert Scientist
GlaxoSmithKline
- Rixensart, Waals Brabant
- Vast
- Voltijds
- Lead the design, planning, organization and analysis of preclinical studies (internal and external), including resources forecasts and activity planification
- Direct management or support to N+1 in development and supervision of lab technicians. This implies an adequate presence to the shop floor where the associated activities are performed. May participate to the performance evaluation, development plan of laboratory staff
- Share expertise in multiple technical competency domains across the preclinical department BE and possibly across Scientific Areas; Scientific/technology watch in own competency domain within defined mission or project
- Lead the development and implementation of new technologies and ensure alignment and state of the art for a given technology across the preclinical department, applying and referring to the GxP/EHS/QA rules in his/her team/lab
- Lead the development of new Read Outs/Laboratory Assays (when applicable)
- Active participation and presentation of lab results in internal meetings, working groups and technical and project team meetings, ensuring quality interpretation and extensive quality check of raw data
- Can be the preclinical representative to project teams; when specific expert in one or more techniques, he or she is the principal representative at technical development teams and preferred point of contact for TRD QC, and VCLAP departments with regards to analytical testing or read-outs. Autonomous in decision making within own area of scientific or technical competencies with direct impact on related project strategy
- Autonomous in writing experimental procedures and scientific reports. Significant contribution (autonomous writing and review by N+1) to and direct interactions with the Regulatory/IP teams for the preparation of the preclinical section of Regulatory/IP documents, in own area of technical expertise
- Responsible for the immunogenicity testing phase (non-GLP conditions) which is part of GLP Toxicity studies, according to the L-SOP9*5529, when applicable
- Lead the development / qualification of release/characterization assay and testing of Phase I/II vaccine lots before transfer to ARD, when applicable.
- May coordinate clinical exploratory testing according to best practices and GSK SOP/Policies, when applicable
- PhD with 3+ years of post-doc and/or job related experience
- Area of specialisationVirology, virology assays and respiratory viruses
- A good understanding of biopharma/vaccine development process
- Must have the ability to work with cross-functional teams and communicate effectively
- Fluent English is a must
- Sound scientific methodology and thinking
- Excellent presentation and communication skills
- Innovative hinking and solution oriented
- Operating at pace and agile decision-making – using evidence and applying judgement to balance pace, rigour and risk.
- Committed to delivering high quality results, overcoming challenges, focusing on what matters, execution.
- Continuously looking for opportunities to learn, build skills and share learning.
- Sustaining energy and well-being
- Building strong relationships and collaboration, honest and open conversations.
- Budgeting and cost-consciousness